Literature DB >> 10469800

Lack of pediatric drug formulations.

M C Nahata1.   

Abstract

Many drugs frequently used in infants and young children are not available in suitable dosage forms. Liquid dosage forms must be prepared extemporaneously, while using appropriate excipients. However, it is critical to determine the stability of various drugs at clinically important concentrations and practical storage conditions. It is of concern that few funding agencies are willing to support research on the development of stable liquid dosage forms for pediatric patients. The need for such data will continue, because it is unlikely that all drugs approved for adults will also be labeled simultaneously for potential use in infants and children. Presentations and publications on stable drug formulations will offer the opportunities for pediatric patients to receive the desired drugs and doses most effectively and safely.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469800

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil.

Authors:  Adriana Cristina de Souza Gonçalves; Adriano Max Moreira Reis; Ana Carolina Marçal Gusmão; Maria Cândida Ferrarez Bouzada
Journal:  Int J Clin Pharm       Date:  2015-04-02

2.  Off label and unlicensed drugs use in paediatric cardiology.

Authors:  M Bajcetic; M Jelisavcic; J Mitrovic; N Divac; S Simeunovic; R Samardzic; R Gorodischer
Journal:  Eur J Clin Pharmacol       Date:  2005-09-08       Impact factor: 2.953

3.  Changes in availability of paediatric medicines in Australia between 1998 and 2002.

Authors:  Jocelyn Chui; June Tordoff; David Reith
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

4.  Candesartan cilexetil in children with hypertension or proteinuria: preliminary data.

Authors:  Giacomo D Simonetti; Rodo O von Vigier; Martin Konrad; Mattia Rizzi; Emilio Fossali; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2006-06-27       Impact factor: 3.714

Review 5.  Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.

Authors:  William Wei Lim Chin; Angelika Joos
Journal:  Eur J Pediatr       Date:  2016-09-19       Impact factor: 3.183

6.  Evaluating Solubility of Celecoxib in Age-Appropriate Fasted- and Fed-State Gastric and Intestinal Biorelevant Media Representative of Adult and Pediatric Patients: Implications on Future Pediatric Biopharmaceutical Classification System.

Authors:  Ramzi Shawahna; Ahed Zyoud; Aseel Haj-Yahia; Raheek Taya
Journal:  AAPS PharmSciTech       Date:  2021-03-01       Impact factor: 3.246

7.  Pharmacovigilance for children's sake.

Authors:  Kristina Star; I Ralph Edwards
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

8.  The need for introducing medication vials tailored for pediatric use. Where do we stand?

Authors:  T Arun Babu; C Venkatesh
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

9.  Solid oral forms availability in children: a cost saving investigation.

Authors:  Audrey Lajoinie; Emilie Henin; Behrouz Kassai; David Terry
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

10.  Extemporaneous suspension of propafenone: attending lack of pediatric formulations in Mexico.

Authors:  Hugo Juárez Olguín; Carmen Flores Pérez; Blanca Ramírez Mendiola; Rafael Coria Jiménez; Eunice Sandoval Ramírez; Janett Flores Pérez
Journal:  Pediatr Cardiol       Date:  2008-06-28       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.